Swetha Kambhampati

717 citations
29 papers · 424 indexed · h-index 11
Topics
CAR-T cell therapy research (9 papers)Multiple Myeloma Research and Treatments (8 papers)Chronic Lymphocytic Leukemia Research (7 papers)

In The Last Decade

Swetha Kambhampati

27 papers receiving 417 citations

Peers

Swetha Kambhampati
Comparison fields: 5 of 65
  • Oncology 196
  • Surgery 113
  • Molecular Biology 101
  • Hematology 83
  • Immunology 72
Replace Arianna Dal Buono with:
Arianna Dal Buono Italy
Yasser Mostafa Kamel United States
Yanyu Wang China
Kai Timrott Germany
Nadia Cecconi Italy
Jyotsna Fuloria United States
Antti Kuuliala Finland
Marc I. Brand United States
Wen‐Li Hwang Taiwan
Swetha Kambhampati relative to Arianna Dal Buono Italy Arianna Dal Buono's profile →
Citations per field
00.5×7.6×
Arianna Dal Buono · 1×
Citations per year

Countries citing papers authored by Swetha Kambhampati

Since Specialization
Citations

This map shows the geographic impact of Swetha Kambhampati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swetha Kambhampati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swetha Kambhampati more than expected).

Fields of papers citing papers by Swetha Kambhampati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swetha Kambhampati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swetha Kambhampati. The network helps show where Swetha Kambhampati may publish in the future.

Co-authorship network of co-authors of Swetha Kambhampati

This figure shows the co-authorship network connecting the top 25 collaborators of Swetha Kambhampati. A scholar is included among the top collaborators of Swetha Kambhampati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swetha Kambhampati. Swetha Kambhampati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 79
3 2
4 10
5 10
6 1
7 7
8 2
9 4
10 42
11 16
12 19
13 67
14 4
15 3
16 25
17 8
18 49
19 11
20 1

About Swetha Kambhampati

Swetha Kambhampati is a scholar working on Hematology, Genetics and Oncology, having authored 29 papers that have together received 424 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Hematology (83 citations), Oncology (196 citations) and Hepatology (53 citations). Swetha Kambhampati has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Nina Shah, Sandy W. Wong, Chiung‐Yu Huang, Vanessa E. Kennedy, Spencer C. Behr, John D. Gordan, Paige M. Bracci, Bridget P. Keenan, Mimi Lo and Robin Kate Kelley. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026